{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:44:07Z","timestamp":1788237847047,"version":"build-2803163510"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000046","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Left atrial appendage (LAA) patency after percutaneous closure is associated with higher thromboembolic risk, especially when detected at later time points after procedure. We aim to investigate the incidence and predictors of persistent LAA patency and its different subtypes at cardiac computed tomography angiography (CCTA) during the first year after LAA closure (LAAC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In the SWISS APERO trial, patients undergoing LAAC were randomly assigned (1:1) to Amulet or Watchman\/FLX across eight European centers and received CCTA follow-up at 45 days and 13 months. The presence, the type and predictors of persistent or new-onset LAA patency at 13 months were investigated by matching 45-day and 13-month CCTAs in an imaging core-lab. Of the 221 randomized patients, 158 (71.5%) were included in the matched 45-day and 13-month CCTA analysis. Residual LAA patency decreased from 66.4 to 50.6% with approximately one-third (30.5%) of 45-day patent appendages (PA) resolved at 13 months. Side-gap leaks at 45 days were the PA subtypes associated with the highest likelihood (86%) of persistence. At 45-day CCTA, the presence of at least two factors among side-gap leak proximal area &amp;gt;37.7\u2005mm2, radial diameter &amp;gt;3\u2005mm or LAA-device angle &amp;gt;39.4\u00b0 (\u2018ARA LAAO\u2019 score \u2265 2) predicted leak persistence at 13-month CCTA with 94.1% sensitivity and 70% specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In a prospective multi-centre cohort of clinically indicated LAAC, approximately two-thirds of 45-day PAs, especially those related to large side-gap leaks with bigger LAA-device off-axis angle, persisted at 13 months, whereas new-onset PA occurred in roughly 1 in every 10 patients.<\/jats:p>\n                    <jats:p>Clinical Trial Registration: URL https:\/\/clinicaltrials.gov Unique Identifier NCT03399851<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeaf232","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T11:46:05Z","timestamp":1754567165000},"page":"1795-1803","source":"Crossref","is-referenced-by-count":6,"title":["Incidence and predictors of persistent left atrial appendage patency and its subtypes after percutaneous closure: a pre-specified analysis of the SWISS-APERO trial"],"prefix":"10.1093","volume":"26","author":[{"given":"Roberto","family":"Galea","sequence":"first","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, University of Bern , Freiburgstrasse 20, Bern 3010 ,","place":["Switzerland"]},{"name":"Department of Cardiology, Hospital Centre of Biel , Biel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Perich Krsnik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, University of Bern , Freiburgstrasse 20, Bern 3010 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Arthur","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Interventional and Pediatric Radiology Bern University Hospital, University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"De Marco","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Monzino Cardiology Center , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Aminian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire de Charleroi , Charleroi ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Meneveau","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Besancon University Hospital, University of Burgundy Franche-Comt\u00e9 , Besancon EA3920 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierik","family":"Heg","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, CTU Bern, University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6029-0597","authenticated-orcid":false,"given":"Christoph","family":"Gr\u00e4ni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, University of Bern , Freiburgstrasse 20, Bern 3010 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-9790","authenticated-orcid":false,"given":"Frederic","family":"Anselme","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Rouen , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Franzone","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, University Federico II University , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Vranckx","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Critical Care Medicine, Hartcentrum Hasselt, Jessa Ziekenhuis , Hasselt ,","place":["Belgium"]},{"name":"Faculty of Medicine and Life Sciences, Hasselt University , Hasselt ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bern University Hospital, University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bedogni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS Policlinico San Donato , Milan, San Donato Milanese ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-3026","authenticated-orcid":false,"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, University of Bern , Freiburgstrasse 20, Bern 3010 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4353-7110","authenticated-orcid":false,"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, University of Bern , Freiburgstrasse 20, Bern 3010 ,","place":["Switzerland"]},{"name":"Cardiocentro Ticino Institute and Universit\u00e0 Della Svizzera Italiana (USI) , Via Tesserete 48, Lugano 6900 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"2025102919515052700_jeaf232-B1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO Registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2025102919515052700_jeaf232-B2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-year outcomes after left atrial appendage closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025102919515052700_jeaf232-B3","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the Amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2025102919515052700_jeaf232-B4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12265-020-10095-4","article-title":"Design and rationale of the Swiss-apero randomized clinical trial: comparison of Amplatzer Amulet vs Watchman device in patients undergoing left atrial appendage closure","volume":"14","author":"Galea","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"2025102919515052700_jeaf232-B5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or Watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea","year":"2022","journal-title":"Circulation"},{"key":"2025102919515052700_jeaf232-B6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.123.067599","article-title":"One-year outcomes after Amulet or Watchman device for percutaneous left atrial appendage closure: a prespecified analysis of the SWISS-APERO randomized clinical trial","volume":"149","author":"Galea","year":"2024","journal-title":"Circulation"},{"key":"2025102919515052700_jeaf232-B7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jacc.2025.03.535","article-title":"3-Year clinical outcomes comparing the Amulet vs Watchman FLX for left atrial appendage closure in patients with atrial fibrillation: results from the SWISS-APERO randomized clinical trial","volume":"86","author":"Galea","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2025102919515052700_jeaf232-B8","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"key":"2025102919515052700_jeaf232-B9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2023.02.027","article-title":"Impact of preprocedural computed tomography on left atrial appendage closure success: a Swiss-Apero trial subanalysis","volume":"16","author":"Galea","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2025102919515052700_jeaf232-B10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"2025102919515052700_jeaf232-B11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.31083\/j.rcm2412343","article-title":"Antithrombotic therapy after percutaneous left atrial appendage closure: evidence, challenges and future directions","volume":"24","author":"Galea R","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"2025102919515052700_jeaf232-B12","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jcin.2024.04.050","article-title":"Position statement on cardiac computed tomography following left atrial appendage occlusion","volume":"17","author":"Korsholm","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"2025102919515052700_jeaf232-B13","first-page":"2071","article-title":"Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices","volume":"99","author":"Korsholm","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025102919515052700_jeaf232-B14","doi-asserted-by":"crossref","first-page":"S1936-878X(25)00247-5","DOI":"10.1016\/j.jcmg.2025.05.004","article-title":"Evolution and clinical relevance of left atrial appendage residual patency after percutaneous closure: a prespecified analysis of the SWISS-APERO trial","volume":"18","author":"Galea","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025102919515052700_jeaf232-B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacep.2021.06.018","article-title":"Temporal changes and clinical implications of delayed peridevice leak following left atrial appendage closure","volume":"8","author":"Afzal","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2025102919515052700_jeaf232-B16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/eurheartj\/ehad828","article-title":"Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis","volume":"45","author":"Samaras","year":"2024","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeaf232\/63979983\/jeaf232.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/26\/11\/1795\/63979983\/jeaf232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/26\/11\/1795\/63979983\/jeaf232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T23:52:02Z","timestamp":1761781922000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/26\/11\/1795\/8226008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,8,7]]},"published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeaf232","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,8,7]]}}}